Abstract
Summary In Germany and other countries, a second wave of corona infections has been observed since July 2020, after the first wave has subsided. We have investigated both waves by a modified SIR-SI infection model, adapted to the data to the Robert-Koch-Institute (RKI) or the Johns-Hopkins-University (JHU).
The first wave is characterized by the SIR model: in a perfect lockdown only a small part of the society is infected and the infections end after a certain time. The SI part considers the incompleteness of any lockdown: at the end of the first wave infections do not completely go down to zero, but continue to rise again, but only slowly due to mouth protection, hygiene and distance keeping. During this first wave the number of deceased people follows the number of infected persons with a fixed time interval and percentage: mostly symptomatic ill people have been tested. This applied to nearly all countries observed, with different intervals and percentages.
In the present second wave, the number of daily infections has risen again significantly in some countries, and it may be questioned whether this is due to the increased number of tests. The answer may be given by looking at the daily number of deaths. In Germany, Austria, Italy, Great Britain and others this number has still remained at a constant level for six weeks. In these countries a second wave of died people has not yet arrived. The increased number of tests include obviously mostly asymptomatically infected persons, who do not fall ill or die from coronavirus. However, in some countries, like USA or Israel, the second wave did arrive. The numbers of infected and deceased people both have grown. A real second wave is a permanent threat to all countries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The authors are retired and have no IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos